voice search
Celvestrant Pfs Injection - 250mg Fulvestrant In Prefilled Syringe | Prescription Only, Anti-cancer Treatment For Post-menopausal Women, 24-month Expiration, Store In Cool Dry Place
Share

Celvestrant Pfs Injection - 250mg Fulvestrant In Prefilled Syringe | Prescription Only, Anti-cancer Treatment For Post-menopausal Women, 24-month Expiration, Store In Cool Dry Place

Price: 560.00 INR / Pack

(500.00 INR + 12% GST)

Get Latest Price

MRP:

999.00 INR / Units

Weight :

150.00 Gram (G)

1 Pack Contains :

1

Minimum Pack Size :

50

In Stock

In Stock

-50+

Product Specifications

GradeMedicine
AppearancePrefilled Syringe
Origin of MedicineChandigarh, Chandigarh, India
Salt CompositionFULVESTRANT
StorageCool and dry place
Expiration Date24 Months
DosageAs prescribed by the physician
Pacakaging (Quantity Per Box)5ml Prefilled Syringe
UsageUsed in the treatment of breast cancer
Medicine TypeAnti Infection Medicines
Dosage FormPrefilled Syringe
Payment TermsTelegraphic Transfer (T/T)
Supply Ability500 Per Week
Delivery Time1 Week
Sample AvailableNo
Sample PolicyContact us for information regarding our sample policy
Packaging DetailsPack Size : 250mg/5ml Syringe InjectionPack Type : Box
Main Domestic MarketChandigarh
ReturnableNo
Unit TypeUnits
MRP999.00 INR
Packsize1
Pkg Box Height5.00 Inches
Mop50
GSTIN12%
Stock Quantity50
Brand NameCelon Labs
Price Typefixed
Pkg Box Length2.00 Inches
Price500.00 INR (Approx.)
Shipping Typeactual
Pkg Box Breadth2.00 Inches
CurrencyINR
Weight150.00 Gram (G)
Minimum Ordered Packs50

Product Overview

Key Features

Type Of Medicines : Allopathic
Dose Strength : 250mg
Processing Type : Pharmaceutical Machine
Prescription/Non Prescription : Prescription
Application : Hospital, Clinic
Supplier Location : Chandigarh, Chandigarh, India
Celvestrant PFS Injection is an estrogen blocker.
It is used in the treatment of breast cancer in women who have gone through menopause. It works by adjusting the level of estrogen and slow down the growth of cancer cells.

Company Details

Sapra Healthcare is a dynamic and innovative multispecialty company committed to enhancing

human health and well-being through a diverse portfolio of pharmaceutical products, medical

devices, and nutraceuticals. Founded in 2023 and headquartered in Chandigarh and New Delhi,

India, Sapra Healthcare is driven by a mission to provide affordable and innovative healthcare

solutions to millions of people worldwide.

Business Type

Distributor, Supplier, Wholesaler

Employee Count

5

Establishment

2023

Working Days

Monday To Saturday

GST NO

04BPRPS0651G1ZR

Payment Mode

Cash in Advance (CID), Others

Certification

ISO 9001

Related Products

Explore Related Categories

More Product From This seller

Seller Details

GST

GST - 04BPRPS0651G1ZR

Chandigarh, Chandigarh

Ceo

Mr Jagmeet

Address

Shop 17, Village Dhanas, Sector 14, Chandigarh, Chandigarh, 160014, India

Report incorrect details

Compare With Similar Products

Price Or Price Range

7170 INR

27500 INR

27500 INR

Minimum Order Quantity

50 Pack/Packs

4 Box/Boxes

4 Box/Boxes

Dosage Form

Prefilled Syringe

injection

injection

Pacakaging (Quantity Per Box)

5ml Prefilled Syringe

1

1

Storage

Cool and dry place

Cool and Dry Place

Cool and Dry Place

Appearance

Prefilled Syringe

Liquid

Liquid

Dosage

As prescribed by the physician

0.75ml

0.75ml

Origin Of Medicine

Chandigarh, Chandigarh, India

India

India

Expiration Date

24 Months

3 Years

3 Years

Payment Terms

Telegraphic Transfer (T/T)

Paypal

Paypal

Main Domestic Market

Chandigarh

Rajasthan

Rajasthan

Delivery Time

1 Week

6 Days

6 Days

Sample Policy

Contact us for information regarding our sample policy

Contact us for information regarding our sample policy

Contact us for information regarding our sample policy

Sample Available

No

Yes

Yes

Packaging Details

Pack Size : 250mg/5ml Syringe Injection Pack Type : Box

Box

Box

Supply Ability

500 Per Week

65 Per Month

65 Per Month

Indication

to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight.

to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight.

People Also Viewed